Hypertension Diagnostics, Inc.
Hypertension Diagnostics, Inc. (HDII) Revenue
Annual & quarterly revenue history · segment & region breakdown
HDII · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsHypertension Diagnostics, Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2021.
Revenue trend
2021 – 1999 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | -$0.00B | -100.00% |
| 2018-12-31 | $0.00B | +$0.00B | +3.10% |
| 2017-12-31 | $0.00B | +$0.00B | +3.11% |
| 2016-12-31 | $0.00B | +$0.00B | +12.95% |
| 2012-06-30 | $0.00B | +$0.00B | +127.36% |
| 2011-06-30 | $0.00B | +$0.00B | +0.36% |
| 2010-06-30 | $0.00B | +$0.00B | +175.05% |
| 2009-06-30 | $0.00B | -$0.00B | -9.25% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Hypertension Diagnostics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Hypertension Diagnostics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Hypertension Diagnostics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HDII revenue · 4 questionsHDII's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2021.
▸ Source: FMP · Hypertension Diagnostics, Inc. SEC filings · GAAP · Hypertension Diagnostics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026